KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to 27.57%.

  • Amgen's EBIT Margin rose 21300.0% to 27.57% in Q4 2025 from the same period last year, while for Dec 2025 it was 24.71%, marking a year-over-year increase of 29900.0%. This contributed to the annual value of 24.71% for FY2025, which is 29900.0% up from last year.
  • Amgen's EBIT Margin amounted to 27.57% in Q4 2025, which was up 21300.0% from 26.43% recorded in Q3 2025.
  • Over the past 5 years, Amgen's EBIT Margin peaked at 40.08% during Q1 2022, and registered a low of 12.69% during Q2 2021.
  • Over the past 5 years, Amgen's median EBIT Margin value was 29.11% (recorded in 2023), while the average stood at 28.06%.
  • As far as peak fluctuations go, Amgen's EBIT Margin crashed by -247400bps in 2021, and later soared by 203100bps in 2022.
  • Over the past 5 years, Amgen's EBIT Margin (Quarter) stood at 33.65% in 2021, then dropped by -3bps to 32.61% in 2022, then tumbled by -52bps to 15.51% in 2023, then surged by 64bps to 25.43% in 2024, then grew by 8bps to 27.57% in 2025.
  • Its last three reported values are 27.57% in Q4 2025, 26.43% for Q3 2025, and 28.94% during Q2 2025.